Recombinant proteins for medical use: the attractions and challenges
β Scribed by Kirston Koths
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 598 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
β¦ Synopsis
Recombinant proteins that have survived the challenges of process development and clinical trials are becoming blockbuster medical products. Growth factors, enzymes and antibodies are being improved by mutational approaches, fused with other proteins, and even chemically modified in vitro. Drug development and testing approaches have advanced, and proteins produced in transgenic animals are new becoming available. Future protein products might include cancer vaccines and therapies for a variety of genetic diseases, but alternative treatments involving gene therapy or small synthetic compounds will provide competition.
π SIMILAR VOLUMES
Recombinant baculoviruses are widely used to express heterologous proteins. They are particularly useful for the high-level expression of eukaryotic proteins with fastidious co-or post-translational processing requirements. The recent publication of the Autographa californica nuclear polyhedrosis vi
## Abstract In this article, recent progress related to the use of different types of polypeptide fusion handles or βtagsβ for the purification of recombinant proteins are critically discussed. In addition, novel aspects of the molecular cassette concept are elaborated, together with areas of poten
Affinity systems based on specific molecular recognition are valuable tools for detection, purification and immobilization of recombinant proteins. Here, novel multipartite affinity fusion vectors were assembled and investigated to allow flexible binding and elution conditions. The rationale for the